Article
Computational assay of H7N9 influenza neuraminidase reveals R292K mutation reduces drug binding affinity.
Scientific reports - 20 Dec 2013
Woods Christopher J, Malaisree Maturos, Long Ben, McIntosh-Smith Simon, Mulholland Adrian J
Abstract excerpt
The emergence of a novel H7N9 avian influenza that infects humans is a serious cause for concern. Of the genome sequences of H7N9 neuraminidase available, one contains a substitution of arginine to lysine at position 292, suggesting a potential for reduced drug binding efficacy. We have performed molecular dynamics simulations of oseltamivir, zanamivir and peramivir bound to H7N9, H7N9-R292K, and a structurally...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
